Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-01-01 @ 7:15 PM
Study NCT ID:
NCT03815058
Status:
COMPLETED
Last Update Posted:
2025-02-07
First Post:
2019-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-21
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-07
First Submit QC Date:
None
Study First Post Date:
2019-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-05
Last Update Post Date:
2025-02-07
Last Update Post Date Type:
ACTUAL